Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

69
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
69
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

3.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

2.3K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.3K
Chemical Synapses01:26

Chemical Synapses

9.5K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.5K
Chemical Synapses01:26

Chemical Synapses

10.9K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
10.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A potentially deadly influenza mimic.

Journal of the American Association of Nurse Practitioners·2019
Same author

Strategies to overcome barriers to pneumococcal vaccination in older adults: an integrative review.

Journal of gerontological nursing·2011
Same journal

Effect of Virtual Reality Glasses on Mild Cognitive Impairment in Older Adults: A Randomized Controlled Trial.

Journal of gerontological nursing·2026
Same journal

Enhancing Nursing Knowledge and Practice in a Rehabilitation Assisted Living Facility Through an Evidence-Based Pressure Injury Prevention Education Model.

Journal of gerontological nursing·2026
Same journal

Home Care Nurses' Experiences With Connected Continuous Glucose Monitoring Systems in Older Adults With Type 2 Diabetes: A Qualitative Study in France.

Journal of gerontological nursing·2026
Same journal

A Community-Based Health Literacy Intervention to Improve Health Literacy, Health Behavior Self-Efficacy, and Quality of Life Among Older Adults With Frailty: A Quasi-Experimental Study.

Journal of gerontological nursing·2026
Same journal

Development and Evaluation of a Standardized Nursing Language Clinical Decision Support System for Long-Term Care Nurses Using GPT-4.0-Generated Nursing Scenarios.

Journal of gerontological nursing·2026
Same journal

Research on Angiotensin Receptor-Neprilysin Inhibitor Use Across Care Settings, the Effectiveness of ALIGN, and Validating Measures Between the Electronic Health Record and Medicare Claims Showcased at #AGS26.

Journal of gerontological nursing·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

11.3K

Myasthenia gravis.

Julie A Koch, Marlee R Steele, Logan M Koch

    Journal of Gerontological Nursing
    |November 28, 2013
    PubMed
    Summary
    This summary is machine-generated.

    Myasthenia gravis (MG), a rare autoimmune neuromuscular disorder, causes fluctuating muscle weakness. Early recognition of MG symptoms by advanced practice nurses is crucial for timely diagnosis and treatment, despite diagnostic challenges.

    More Related Videos

    Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction
    11:07

    Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

    Published on: April 14, 2022

    2.1K
    Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models
    04:30

    Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models

    Published on: March 8, 2024

    2.0K

    Related Experiment Videos

    Last Updated: May 5, 2026

    Antigenic Liposomes for Generation of Disease-specific Antibodies
    10:31

    Antigenic Liposomes for Generation of Disease-specific Antibodies

    Published on: October 25, 2018

    11.3K
    Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction
    11:07

    Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

    Published on: April 14, 2022

    2.1K
    Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models
    04:30

    Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models

    Published on: March 8, 2024

    2.0K

    Area of Science:

    • Neurology
    • Immunology
    • Nursing Practice

    Background:

    • Myasthenia gravis (MG) is a rare, chronic autoimmune neuromuscular disorder.
    • It is characterized by fluctuating skeletal muscle weakness and fatigue.
    • MG presents diagnostic challenges for advanced practice nurses (APNs) due to low incidence and unrecognized symptoms, often leading to delayed diagnosis.

    Purpose of the Study:

    • To highlight the importance of recognizing clinical features for prompt diagnosis of myasthenia gravis.
    • To inform APNs about symptom variations and diagnostic tools for myasthenia gravis.
    • To emphasize the role of APNs in collaborating with neuromuscular specialists for patient care.

    Main Methods:

    • Review of clinical presentation, diagnosis, and treatment principles for myasthenia gravis.
    • Utilized an individual case example of an older adult with myasthenia gravis.
    • Focused on the experience from clinical presentation through treatment.

    Main Results:

    • Delayed diagnosis (1-2 years) is common due to unrecognized symptoms and low incidence.
    • Awareness of MG symptom variations and diagnostic tools can prevent treatment delays.
    • APNs can effectively collaborate with specialists, contributing to comprehensive patient management.

    Conclusions:

    • Early recognition of myasthenia gravis clinical features by APNs is vital.
    • APNs play a key role in facilitating timely diagnosis and collaborative care for MG patients.
    • Understanding general treatment principles enables APNs to support neuromuscular specialists.